Christopher Anzalone
Chief Executive Officer at Arrowhead Pharmaceuticals. Based in Pasadena, California.
- Rank
- 1037th of 14,644
- Companies held
- 1
- Largest holding
- ARWR, 100.0% of total
- Latest SEC filing
- Jan 2, 2026
What the $164M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals ARWR Common Stock | Directly | 3,792,739 | $43.12 | $164M | 100.0% | Form 4, Jan 2, 2026 |
Share counts are the amounts Christopher Anzalone reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | Sold | ARWR | 5,771 | $66.39 | $383K | View |
| Jan 2, 2026 | Sold | ARWR | 7,416 | $65.88 | $489K | View |
| Dec 29, 2025 | Sold | ARWR | 16,545 | $68.69 | $1.1M | View |
| Dec 29, 2025 | Sold | ARWR | 35,181 | $69.33 | $2.4M | View |
| Dec 22, 2025 | Sold | ARWR | 2,574 | $68.85 | $177K | View |
| Dec 22, 2025 | Sold | ARWR | 10,012 | $68.33 | $684K | View |
| Dec 19, 2025 | Sold | ARWR | 3,979 | $66.67 | $265K | View |
| Dec 19, 2025 | Sold | ARWR | 8,147 | $68.01 | $554K | View |
| Dec 19, 2025 | Sold | ARWR | 1,319 | $68.48 | $90K | View |
| Dec 17, 2025 | Sold | ARWR | 35,750 | $64.51 | $2.3M | View |
| Dec 17, 2025 | Sold | ARWR | 982 | $65.53 | $64K | View |
| Dec 17, 2025 | Sold | ARWR | 1,981 | $66.30 | $131K | View |
| Dec 17, 2025 | Sold | ARWR | 46,287 | $63.55 | $2.9M | View |
| Dec 16, 2025 | Sold | ARWR | 3,221 | $67.87 | $219K | View |
| Dec 16, 2025 | Sold | ARWR | 166 | $66.77 | $11K | View |
| Dec 16, 2025 | Sold | ARWR | 1,300 | $65.77 | $86K | View |
| Dec 16, 2025 | Sold | ARWR | 1,000 | $64.96 | $65K | View |
| Dec 16, 2025 | Sold | ARWR | 8,476 | $62.94 | $533K | View |
| Dec 16, 2025 | Sold | ARWR | 14,095 | $62.12 | $876K | View |
| Dec 16, 2025 | Sold | ARWR | 10,963 | $61.25 | $671K | View |
| Dec 16, 2025 | Sold | ARWR | 8,416 | $60.51 | $509K | View |
| Dec 16, 2025 | Sold | ARWR | 6,661 | $64.29 | $428K | View |
| Dec 15, 2025 | Sold | ARWR | 8,147 | $69.96 | $570K | View |
| Dec 15, 2025 | Sold | ARWR | 21,321 | $69.28 | $1.5M | View |
| Dec 15, 2025 | Sold | ARWR | 100,532 | $68.67 | $6.9M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1034 | Brian E. Lane CHIEF EXECUTIVE OFF., Comfort Systems USA. Houston, TX | $164M |
| 1035 | Tim Chao-Ming Chen Chief Executive Officer, NerdWallet. Scottsdale, AZ | $164M |
| 1036 | Albert Gore, Jr Director, Apple. Cupertino, CA | $164M |
| 1037 | Christopher Anzalone Chief Executive Officer, Arrowhead Pharmaceuticals. Pasadena, CA | $164M |
| 1038 | Robert Mehrabian Executive Chairman, Teledyne Technologies. Thousand Oaks, CA | $163M |
| 1039 | Carolyn Schwab-Pomerantz Director, The Charles Schwab. Westlake, TX | $163M |
| 1040 | Divesh Makan 10% owner, Procore Technologies. San Francisco, CA | $163M |
Other Arrowhead Pharmaceuticals insiders
All ARWR insiders- Patrick O'Brien$23.6MCOO. #4593 overall
- Kenneth Myszkowski$19.6MChief Financial Officer. #5285 overall
- James Hamilton$9.8MChief Medical Officer. #8947 overall
- Javier San Martin$8.6MChief Medical Officer. #9841 overall
- Daniel Joseph Apel$7.0MChief Financial Officer. #11396 overall
- Tracie Oliver$5.5MChief Commercial Officer. #13589 overall
Questions
How much stock does Christopher Anzalone own?
Christopher Anzalone holds $163,542,906 in listed stock based on SEC filings and current prices, mostly Arrowhead Pharmaceuticals (ARWR). That ranks 1037th on the Stock Rich List.
Is this Christopher Anzalone's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Christopher Anzalone last buy or sell stock?
The most recent open-market trade on file is a sale of 5,771 ARWR shares on Jan 2, 2026 at $66.39.